Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Hund

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
JMIR Research Protocols|February 6, 2024
Validation of an Anti-Müllerian Hormone Cutoff for Polycystic Ovarian Morphology in the Diagnosis of Polycystic Ovary Syndrome in the HARMONIA Study: Protocol for a Prospective, Noninterventional StudyTerhi T Piltonen, Deirdre Allegranza, Martin Hund, et al.
Hypertension in Pregnancy|January 29, 2015
Influence of the sFlt-1/PlGF ratio on clinical decision-making in women with suspected preeclampsia--the PreOS study protocolMartin Hund, Wilma Verhagen-Kamerbeek, Manfred Reim, et al.
Molecular Biology of the Cell|August 20, 2003
SWAP-70 identifies a transitional subset of actin filaments in motile cellsPirta Hilpelä, Pia Oberbanscheidt, Penelope Hahne, et al.
The Lancet. Child & Adolescent Health|August 19, 2018
Screening for fetal growth restriction using ultrasound and the sFLT1/PlGF ratio in nulliparous women: a prospective cohort studyFrancesca Gaccioli, Ulla Sovio, Emma Cook, et al.
Hypertension (Dallas, Tex. : 1979)|February 8, 2017
Prediction of Preeclampsia Using the Soluble fms-Like Tyrosine Kinase 1 to Placental Growth Factor Ratio: A Prospective Cohort Study of Unselected Nulliparous WomenUlla Sovio, Francesca Gaccioli, Emma Cook, et al.
Fertility and Sterility|September 28, 2021
Antimüllerian hormone to determine polycystic ovarian morphologyAlexandra Dietz de Loos, Martin Hund, Katharina Buck, et al.
Reproductive Biomedicine Online|December 14, 2017
The utility of anti-Müllerian hormone in women with chronic kidney disease, on haemodialysis and after kidney transplantationSokratis Stoumpos, Jennifer Lees, Paul Welsh, et al.
Frontiers in Cardiovascular Medicine|September 9, 2021
Short-Term Prediction of Preeclampsia in Chinese Women Using the Soluble fms-Like Tyrosine Kinase 1/Placental Growth Factor Ratio: A Sub-Analysis of the PROGNOSIS Asia StudyJinsong Gao, Xianghua Huang, Wen Di, et al.
Frontiers in Medicine|December 19, 2018
Diagnostic Accuracy of Different Soluble fms-Like Tyrosine Kinase 1 and Placental Growth Factor Cut-Off Values in the Assessment of Preterm and Term Preeclampsia: A Gestational Age Matched Case-Control StudyEvelyn A Huhn, Andrea Kreienbühl, Ina Hoffmann, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|March 17, 2021
Short-term prediction of preeclampsia using the sFlt-1/PlGF ratio: a subanalysis of pregnant Japanese women from the PROGNOSIS Asia studyAkihide Ohkuchi, Shigeru Saito, Tatsuo Yamamoto, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
JMIR Research Protocols|February 6, 2024
Validation of an Anti-Müllerian Hormone Cutoff for Polycystic Ovarian Morphology in the Diagnosis of Polycystic Ovary Syndrome in the HARMONIA Study: Protocol for a Prospective, Noninterventional StudyTerhi T Piltonen, Deirdre Allegranza, Martin Hund, et al.
Hypertension in Pregnancy|January 29, 2015
Influence of the sFlt-1/PlGF ratio on clinical decision-making in women with suspected preeclampsia--the PreOS study protocolMartin Hund, Wilma Verhagen-Kamerbeek, Manfred Reim, et al.
Molecular Biology of the Cell|August 20, 2003
SWAP-70 identifies a transitional subset of actin filaments in motile cellsPirta Hilpelä, Pia Oberbanscheidt, Penelope Hahne, et al.
The Lancet. Child & Adolescent Health|August 19, 2018
Screening for fetal growth restriction using ultrasound and the sFLT1/PlGF ratio in nulliparous women: a prospective cohort studyFrancesca Gaccioli, Ulla Sovio, Emma Cook, et al.
Hypertension (Dallas, Tex. : 1979)|February 8, 2017
Prediction of Preeclampsia Using the Soluble fms-Like Tyrosine Kinase 1 to Placental Growth Factor Ratio: A Prospective Cohort Study of Unselected Nulliparous WomenUlla Sovio, Francesca Gaccioli, Emma Cook, et al.
Fertility and Sterility|September 28, 2021
Antimüllerian hormone to determine polycystic ovarian morphologyAlexandra Dietz de Loos, Martin Hund, Katharina Buck, et al.
Reproductive Biomedicine Online|December 14, 2017
The utility of anti-Müllerian hormone in women with chronic kidney disease, on haemodialysis and after kidney transplantationSokratis Stoumpos, Jennifer Lees, Paul Welsh, et al.
Frontiers in Cardiovascular Medicine|September 9, 2021
Short-Term Prediction of Preeclampsia in Chinese Women Using the Soluble fms-Like Tyrosine Kinase 1/Placental Growth Factor Ratio: A Sub-Analysis of the PROGNOSIS Asia StudyJinsong Gao, Xianghua Huang, Wen Di, et al.
Frontiers in Medicine|December 19, 2018
Diagnostic Accuracy of Different Soluble fms-Like Tyrosine Kinase 1 and Placental Growth Factor Cut-Off Values in the Assessment of Preterm and Term Preeclampsia: A Gestational Age Matched Case-Control StudyEvelyn A Huhn, Andrea Kreienbühl, Ina Hoffmann, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|March 17, 2021
Short-term prediction of preeclampsia using the sFlt-1/PlGF ratio: a subanalysis of pregnant Japanese women from the PROGNOSIS Asia studyAkihide Ohkuchi, Shigeru Saito, Tatsuo Yamamoto, et al.
Pageof 4